Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot. 7163-CL-3201: A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients
Gallon, Lorenzo
(PD/PI)
Medicine, Nephrology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
10/13/17
→
10/13/20
Funding
Astellas Pharma Global Development, Inc.
(Prot. 7163-CL-3201)
View all
View less